Sorry, I don't understand your search. ×
Back to Search Start Over

PNS121 DOES THE CHOICE OF INDEPENDENT EXPERT COMMITTEE AFFECT ICER OUTCOMES?

PNS121 DOES THE CHOICE OF INDEPENDENT EXPERT COMMITTEE AFFECT ICER OUTCOMES?

Authors :
Majeed, B.
Macaulay, R.
Tang, M.
Source :
Value in Health. 2020 Supplement 1, Vol. 23, pS306-S306. 1p.
Publication Year :
2020

Abstract

The Institute for Clinical and Economic Review (ICER) publishes reports on the clinical and economic value of drugs for US payers. Each report is subject to a public meeting by one of three independent expert committees (the California Technology Assessment Forum [CTAF], Midwest Comparative Effectiveness Public Advisory Council [CEPAC], and New England CEPAC) discusses the report and votes on the evidence presented. Of the 51 votes for healthcare value, most drugs had a majority vote of low or intermediate value: CTAF: 9 (90%); Midwest CEPAC: 12 (86%); New England CEPAC: 22 (81%). [Extracted from the article]

Details

Language :
English
ISSN :
10983015
Volume :
23
Database :
Academic Search Index
Journal :
Value in Health
Publication Type :
Academic Journal
Accession number :
144264898
Full Text :
https://doi.org/10.1016/j.jval.2020.04.1124